Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

CJC-1295 / Ipamorelin Blend Dosage & Reconstitution

Mod GRF 1-29 + Ipamorelin, typically 5 mg + 5 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

1.667 mg/mL · 1667 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — CJC-1295 / Ipamorelin BlendYour Answer

24Draw To This Line
0.24That's This Many mL
25Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 24
10 mg ÷ 6 mL = 1.667 mg/mL  →  400 mcg ÷ 1.667 mg/mL = 0.24 mL  →  × 100 = 24 units
Looks good. Draw to 24 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 25 doses.

2Week-By-Week Plan — CJC-1295 / Ipamorelin Blend

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Low reported 200 mcg 1× daily (100 mcg each) 0.12 mL 12 u 50 doses
Standard 400 mcg 1–2× daily (200 mcg each) 0.24 mL 24 u 25 doses
Upper reported 600 mcg 1–2× daily (300 mcg each) 0.36 mL 36 u 16 doses
Weeks until the top dose
4 weeks
Peptide used getting there
8.4 mg
Vials you'll need
1 × 10 mg
Once you're at the top dose
16.8 mg / 4 wk · 1.68 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — CJC-1295 / Ipamorelin Blend

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 200 mcg daily 0.12 mL 12 u 14 2.8 mg
Weeks 3–4 400 mcg daily 0.24 mL 24 u 14 5.6 mg
Week 5 onward
per 4 weeks from here on
600 mcg daily 0.36 mL 36 u 28 16.8 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About CJC-1295 / Ipamorelin BlendAbout This Peptide

Multi-Compound Blends
Also known as
Mod GRF 1-29 + Ipamorelin, typically 5 mg + 5 mg
Class
Multi-Compound Blends
Route
Subcutaneous
Half-life
Mixed (~30 min / ~2 h)
Evidence tier
Preclinical

A GHRH analogue paired with a selective ghrelin receptor agonist — the pairing rationale is that the two receptors act synergistically on GH release. A 10 mg vial holds 5 mg of each; a 200 mcg dose therefore delivers 100 mcg of each.

Buy CJC-1295 / Ipamorelin Blendthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
Synergistic GH release with combined GHRH and GHRP administration Bowers CY, et al. JCEM, 1990s
The classic demonstration of GHRH + GHRP synergy that justifies the pairing.
Find on PubMed ↗
See component entries: CJC-1295 no DAC, Ipamorelin Component literature
No trial has tested this specific fixed-ratio product.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

BPC-157 / KPV Blend

An equal-parts repair and anti-inflammatory pairing — 10 mg of each in a 20 mg vial, so every dose splits evenly down the middle a…

TB-500 / BPC-157 / KPV Blend

An equal-thirds repair and anti-inflammatory combination — 10 mg of each component in a 30 mg vial. Because the three are pooled a…

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.